当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › VACCINE杂志
VACCINE
基本信息
期刊名称 VACCINE
VACCINE
期刊ISSN 0264-410X
期刊官方网站 http://www.journals.elsevier.com/vaccine
是否OA
出版商 Elsevier BV
出版周期 Weekly
始发年份 1983
年文章数 1037
最新影响因子 3.269(2018)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 IMMUNOLOGY 免疫学3区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.18 1.759 1.128
Veterinary
General Veterinary
3 / 165 98%
Immunology and Microbiology
General Immunology and Microbiology
13 / 41 69%
Medicine
Public Health, Environmental and Occupational Health
53 / 489 89%
Medicine
Infectious Diseases
54 / 272 80%
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
62 / 165 62%
补充信息
自引率 14.20%
H-index 151
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0264-410X%5BISSN%5D
投稿指南
期刊投稿网址 http://ees.elsevier.com/jvac/
收稿范围

Vaccine has an open access mirror journal Vaccine: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. 

Vaccine is unique in publishing the highest quality science across all disciplinesrelevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. Our submission categoriesindicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions. We also invite authors to submit relevant basic science and clinical reviews, methodological articles, opinion and commentary pieces, visual pieces, and letters. Authors are required to consult the Guide for Authors as this is a dynamic set of submission guidelines and is therefore subject to change. The Editors retain the right to desk reject submissions without peer review where it is clear that the Guide for Authors and the submission categories have not been consulted.

收录体裁
research papers, review articles, short communications and letters
投稿指南 https://www.elsevier.com/journals/vaccine/0264-410x/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/vaccine/0264-410x/guide-for-authors
编辑信息
Editor-in-Chief
Contact Dr. Greg Poland via Managing Editor Sandra Isidean
Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
Managing Editor

Dr. Sandra Isidean

McGill University, Montréal, Quebec, Canada 
Reviews Editor

Dr. Kathleen M. Neuzil

University of Maryland School of Medicine, Baltimore, Maryland, United States 
Associate Editors
Hammersmith Hospital, London, United Kingdom 
Meningococcal Reference Unit, Manchester, United Kingdom Bacterial vaccines and clinical trials
Centers for Disease Control and Prevention, Atlanta, Georgia, United States  Vaccine Safety & Policy
Animal and Plant Health Agency, Addlestone, United Kingdom  Zoonosis and neglected tropical diseases
The University of Hong Kong, Department of Medicine, Hong Kong SAR, China  Influenza, vaccine, antiviral
Professor Sylvia van den Hurk
University of Saskatchewan, Saskatoon, Saskatchewan, Canada  Human and veterinary vaccines; viral vaccines; immunology and animal models; adjuvants
The University of Tokyo, Bunkyo-Ku, Tokyo, Japan  Adjuvant; Flu vaccine; malaria vaccine; DNA vaccine; regulatory science; innate immunity
Kaiser Permanente Southern California, Pasadena, California, United States  Epidemiology and clinical trials
Icahn School of Medicine at Mount Sinai, New York, New York, United States  Influenza, Hemagglutinin, Neuraminidase, Stalk, Heterosubtypic Immunity
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States  Economics, operations research, logistics, modelling, and policy
The University of Adelaide Faculty of Engineering Computer and Mathematical Sciences School of Chemical Engineering and Advanced Materials, Adelaide, South Australia, Australia  Vaccine engineering and manufacture; nanoparticle vaccines; nanoemulsions
Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States  Study Design, Biostatistical Methods, Vaccine Safety, Vaccine Effectiveness, Surveillance
Emory University, Atlanta, Georgia, United States  Polio; measles; improving immunization coverage; vaccine mandates; vaccine safety
University of California Berkeley, Berkeley, California, United States  Epidemiology; Vaccine Efficacy and Effectiveness; Vaccine Safety; Vaccine Policy
Editorial Board

Dr. Carl Alving

Walter Reed Army Institute of Research, Silver Spring, Maryland, United States

Dr. Jon K. Andrus

Pan American Health Organization, Washington, District of Columbia, United States

Professor Bernard Arulanandam

University of Texas at San Antonio, San Antonio, Texas, United States

Professor Robert L. Atmar

Baylor College of Medicine Department of Molecular Virology and Microbiology, Houston, Texas, United States
Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia

Dr. Noel Barrett

Baxter Innovations GmbH Orth an der Donau, Orth an der Donau, Austria

Dr. Kenneth Beagley

Queensland University of Technology Institute of Health and Biomedical Innovation, Brisbane, Australia

Dr. Martin Beer

Friedrich-Loeffler-Institute Federal Research Institute for Animal Health, Greifswald, Germany

Professor Igor Belyakov

Consultant Company for Immunology and Vaccine Development, Gaithersburg, Maryland, USA

Professor Steven Black

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Professor Paolo Bonanni

University of Florence, Firenze, Italy
Catalan Institute of Oncology Cancer Epidemiology Research Programme, Barcelona, Spain

Professor Prosper Boyaka

OHIO STATE UNIVERSITY, Columbus, Ohio, United States

Dr. David Briles

University of Alabama at Birmingham, Birmingham, Alabama, United States

Dr. Alexander Bukreyev

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON, Galveston, Texas, United States

Dr. Antonella Caputo

University of Ferrara, Ferrara, Italy

Dr. Antonio Cassone

University of Perugia, Perugia, Italy

Professor Yung-Fu Chang

Cornell University, Ithaca, New York, United States

Professor Allan Cripps

Griffith University - Gold Coast Campus, Southport, Australia

Dr. Roy Curtiss III

University of Florida, Gainesville, Florida, United States

Professor Ron Dagan

Soroka Medical Center, Be'er Sheva, Israel

Dr. Pierre van Damme

University of Antwerp, Antwerpen, Belgium

Dr. Amanda Dempsey

University of Colorado Denver - Anschutz Medical Campus, Aurora, Colorado, United States

Dr. Betty Dodet

Dodet Bioscience, Caluire et Cuire, France

Dr. Philippe Duclos

World Health Organization Department of Immunization Vaccines and Biologicals, Genève 27, Switzerland

Professor Kathryn M. Edwards

Vanderbilt University School of Medicine, Nashville, Tennessee, United States

Dr. Barbara Ensoli

National Institute of Health, Roma, Italy
Translational Research Institute, South Brisbane, Australia

Dr. Tong-Ming Fu

Merck Research Laboratories West Point, Lansdale, Pennsylvania, United States

Professor Jose de la Fuente

Research Institute of Wildlife Resources, Ciudad Real, Spain

Dr. Kohtaro Fujihashi

University of Alabama at Birmingham, Birmingham, Alabama, United States

Dr. James Galen

University of Maryland Baltimore, Baltimore, Maryland, United States

Dr. Adolfo Garcia-Sastre

Icahn School of Medicine at Mount Sinai Department of Microbiology, New York, New York, United States

Dr. John W. Glasser

Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Dr. Dan Granoff

UCSF Benioff Children's Hospital Oakland, Oakland, California, United States

Dr. Marie Griffin

VANDERBILT UNIVERSITY MEDICAL CENTER, Nashville, Tennessee, United States

Dr. Carlos Guzman

Helmholtz Centre for Infection Research Department of Vaccine and Applied Microbiology, Braunschweig, Germany

Dr. Robert Hall

National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States

Professor Scott Halperin

Dalhousie University, Halifax, Nova Scotia, Canada

Professor Ali Harandi

University of Gothenburg, Goteborg, Sweden

Dr. Jorma Hinkula

Linköping University, Linköping, Sweden

Dr. Kiyoko Iwatsuki-Horimoto

The Institute of Medical Science The University of Tokyo, Minato-Ku, Japan

Dr. Lisa Jackson

Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States

Professor Rodrigo Jiménez-García

Rey Juan Carlos University, Madrid, Spain

Dr. Mark Jit

Public Health England, London, United Kingdom

Professor Yoshihiro Kawaoka

University of Wisconsin at Madison, School of Veterinary Medicine; Influenza Research Inst., Dept. of Pathobiological Sciences, Madison, Wisconsin, United States

Professor Stephen Kent

The University of Melbourne Department of Microbiology and Immunology, Melbourne, Victoria, Australia

Dr. Ki Hong Kim

Pukyong National University, Busan, Korea, Republic of

Dr. Dennis Klinman

Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States

Professor Keith Klugman

Bill and Melinda Gates Foundation, Pneumonia program, Seattle, Washington, United States

Dr. Eiji Konishi

Osaka University Research Institute for Microbial Diseases, Osaka, Japan

Professor Thomas Lehner

Guy's Hospital, London, United Kingdom

Dr. Margaret Liu

Karolinska Institute, Stockholm, Sweden

Professor Pier Luigi Lopalco

European Centre for Disease Prevention and Control, Solna, Sweden

Dr. Shan Lu

University of Massachusetts Medical School, Worcester, Massachusetts, United States

Dr. Raina MacIntyre

University of New South Wales, Sydney, New South Wales, Australia

Dr. Helena Maltezou

National Public Health Organization, Athens, Greece

Dr. Tetsuro Matano

National Institute of Infectious Diseases AIDS Research Center, Tokyo, Japan

Professor Janet McElhaney

UConn Health, Farmington, Connecticut, United States

Dr. Peter McIntyre

Children's Hospital at Westmead, Westmead, Australia

Dr. Dennis Metzger

Albany Medical College, Albany, New York, United States

Dr. Mark Miller

National Institutes of Health, Bethesda, Maryland, United States

Dr. Anthony Newall

University of New South Wales, Sydney, New South Wales, Australia

Professor Peter Newman

University of Toronto, Toronto, Ontario, Canada

Dr. Saad Omer

Emory University, Atlanta, Georgia, United States

Dr. Slobodan Paessler

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON, Galveston, Texas, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Dr. Marcela Pasetti

University of Maryland Baltimore, Baltimore, Maryland, United States

Dr. Stephen Pelton

Boston Medical Center, Boston, Massachusetts, United States

Dr. Michael Pichichero

Rochester General Hospital Research Institute, New York, New York, United States

Dr. Stanley Plotkin

Sanofi Pasteur, Doylestown, Pennsylvania, United States

Professor Maarten Postma

University of Groningen, Groningen, Netherlands

Professor Nicola Principi

University of Milan, Milano, Italy

Professor Roman Prymula

Charles University Faculty of Medicine in Hradec Kralove Department of Social Medicine, Hradec Králové, Czech Republic

Dr. Conrad Quinn

Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Dr. Rino Rappuoli

GSK Vaccines SRL, Siena, Italy

Professor Steven Reed

Infectious Disease Research Institute, Seattle, Washington, United States

Dr. Guus Rimmelzwaan

Erasmus University Rotterdam, Rotterdam, Netherlands

Dr. Lance Rodewald

Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Dr. Ted Ross

Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, United States

Dr. Mark Rozenbaum

Pfizer BV, Capelle Aan Den Ijssel, Netherlands
Ghent University, Gent, Belgium

Dr. William Schaffner

Vanderbilt University School of Medicine, Nashville, Tennessee, United States

Dr. David Scheifele

BC Children's Hospital, Vancouver, British Columbia, Canada

Dr. Claire-Anne Siegrist

University of Geneva Center of Vaccinology and Neonatal Immunology, Genève, Switzerland

Dr. Mark Slifka

Oregon Health & Science University Oregon National Primate Research Center, Beaverton, Oregon, United States

Dr. Kanta Subbarao

National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States

Professor Andreas Suhrbier

QIMR Berghofer Medical Research Institute, Herston, Australia

Dr. Rik de Swart

Erasmus Medical Center, Rotterdam, Netherlands

Dr. Keipp Talbot

VANDERBILT UNIVERSITY MEDICAL CENTER, Nashville, Tennessee, United States

Dr. Geraldine Taylor

Pirbright Institute - Compton, Newbury, United Kingdom

Dr. Ralph Tripp

The University of Georgia, Athens, Georgia, United States

Dr. Takafumi Tsuboi

Ehime University Proteo-Science Center Cell-Free Science and Technology Research, Matsuyama, Japan

Professor Bruce G. Weniger

Chiang Mai University Research Institute for Health Sciences, Chiang Mai, Thailand

Dr. Cynthia Whitney

Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Dr. Sabine Wicker

Goethe University Frankfurt, Frankfurt am Main, Germany

Prof. Dr. Fred Zepp

Johannes Gutenberg University, Mainz, Germany

Dr. Qinjian Zhao

Xiamen University, Xiamen, China

Dr. Gregory Zimet

Indiana University School of Medicine, Indianapolis, Indiana, United States


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug